The word "stable" appeared regarding a patient from Cohort 1 who had been on the lowest 2mg dose for 6 months being moved to Cohort 2 announced 28th March 2023. At the time this seemed quite significant to me.
Perhaps the ALSFRS-R will reveal a few surprises. MT was very enthusiastic at his EGM presentation. Could it be that there will be a couple of outliers in the data exceeding even the wildest expectations? I certainly hope so.
The word "stable" appeared regarding a patient from Cohort 1 who...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.24M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $244.3K | 1.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 257206 | 7 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |